Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 50 entries
Sorted by: Best Match Show Resources per page
Histamine and the classic antihistamines.

Drug news & perspectives

Sneader W.
PMID: 12806427
Drug News Perspect. 2001 Dec;14(10):618-24.

The first steps leading to the recognition of histamine's biological activity were taken in 1907. The existence of histamine in the body was finally recognized by 1910, and many researchers were keen to establish its physiological role, especially with...

Cite
Sneader W. Histamine and the classic antihistamines. Drug News Perspect. 2001;14(10):618-24
Sneader, W. (2001). Histamine and the classic antihistamines. Drug news & perspectives, 14(10), 618-24.
Sneader, W. "Histamine and the classic antihistamines." Drug news & perspectives vol. 14,10 (2001): 618-24.
Sneader W. Histamine and the classic antihistamines. Drug News Perspect. 2001 Dec;14(10):618-24. PMID: 12806427.
Copy Download .nbib Format: NLM
Epinephrine analogues.

Drug news & perspectives

Sneader W.
PMID: 12806441
Drug News Perspect. 2001 Nov;14(9):539-43. doi: 10.1358/dnp.2001.14.9.858410.

Tyramine was the first epinephrine analogue to be introduced into medicine, in the early 1900s. It was followed by ephedrine and pseudoephedrine in the 1920s and by the amfetamines a decade later. The popularity of the amfetamines grew throughout...

Cite
Sneader W. Epinephrine analogues. Drug News Perspect. 2001;14(9):539-43doi: 10.1358/dnp.2001.14.9.858410.
Sneader, W. (2001). Epinephrine analogues. Drug news & perspectives, 14(9), 539-43. https://doi.org/10.1358/dnp.2001.14.9.858410
Sneader, W. "Epinephrine analogues." Drug news & perspectives vol. 14,9 (2001): 539-43. doi: https://doi.org/10.1358/dnp.2001.14.9.858410
Sneader W. Epinephrine analogues. Drug News Perspect. 2001 Nov;14(9):539-43. doi: 10.1358/dnp.2001.14.9.858410. PMID: 12806441.
Copy Download .nbib Format: NLM
Decorating graphene with size-selected few-atom clusters: a novel approach to investigate graphene-adparticle interactions.

Nanoscale

Scheerder JE, Picot T, Reckinger N, Sneyder T, Zharinov VS, Colomer JF, Janssens E, Van de Vondel J.
PMID: 28703819
Nanoscale. 2017 Jul 27;9(29):10494-10501. doi: 10.1039/c7nr02217d.

We investigated the interaction between size-selected Au

Cite
Scheerder JE, Picot T, Reckinger N, et al. Decorating graphene with size-selected few-atom clusters: a novel approach to investigate graphene-adparticle interactions. Nanoscale. 2017;9(29):10494-10501doi: 10.1039/c7nr02217d.
Scheerder, J. E., Picot, T., Reckinger, N., Sneyder, T., Zharinov, V. S., Colomer, J. F., Janssens, E., & Van de Vondel, J. (2017). Decorating graphene with size-selected few-atom clusters: a novel approach to investigate graphene-adparticle interactions. Nanoscale, 9(29), 10494-10501. https://doi.org/10.1039/c7nr02217d
Scheerder, Jeroen E, et al. "Decorating graphene with size-selected few-atom clusters: a novel approach to investigate graphene-adparticle interactions." Nanoscale vol. 9,29 (2017): 10494-10501. doi: https://doi.org/10.1039/c7nr02217d
Scheerder JE, Picot T, Reckinger N, Sneyder T, Zharinov VS, Colomer JF, Janssens E, Van de Vondel J. Decorating graphene with size-selected few-atom clusters: a novel approach to investigate graphene-adparticle interactions. Nanoscale. 2017 Jul 27;9(29):10494-10501. doi: 10.1039/c7nr02217d. PMID: 28703819.
Copy Download .nbib Format: NLM
The prehistory of psychotherapeutic agents.

Journal of psychopharmacology (Oxford, England)

Sneader W.
PMID: 22282937
J Psychopharmacol. 1990 Jan;4(3):115-9. doi: 10.1177/026988119000400303.

In the absence of a coherent understanding of the pathological basis of a disease, only serendipity can provide effective drugs for its treatment. Nowhere is this more evident than in an examination of the history of psychotherapeutic drugs (Sneader,...

Cite
Sneader W. The prehistory of psychotherapeutic agents. J Psychopharmacol. 1990;4(3):115-9doi: 10.1177/026988119000400303.
Sneader, W. (1990). The prehistory of psychotherapeutic agents. Journal of psychopharmacology (Oxford, England), 4(3), 115-9. https://doi.org/10.1177/026988119000400303
Sneader, W. "The prehistory of psychotherapeutic agents." Journal of psychopharmacology (Oxford, England) vol. 4,3 (1990): 115-9. doi: https://doi.org/10.1177/026988119000400303
Sneader W. The prehistory of psychotherapeutic agents. J Psychopharmacol. 1990 Jan;4(3):115-9. doi: 10.1177/026988119000400303. PMID: 22282937.
Copy Download .nbib Format: NLM
Hydrothermal synthesis and spectroscopic properties of a new glaserite material, K3RE(VO4)2 (RE = Sc, Y, Dy, Ho, Er, Yb, Lu, or Tm) with potential lasing and optical properties.

Inorganic chemistry

Kimani MM, Thompson L, Snider W, McMillen CD, Kolis JW.
PMID: 23205611
Inorg Chem. 2012 Dec 17;51(24):13271-80. doi: 10.1021/ic301922e. Epub 2012 Dec 03.

A new series of materials of the glaserite family with the general formula K(3)RE(VO(4))(2)(RE = Sc, Y, Dy, Ho, Er, Tm, Yb, and Lu) have been hydrothermally synthesized using 10 M K(2)CO(3) at 560 °C and characterized by single...

Cite
Kimani MM, Thompson L, Snider W, et al. Hydrothermal synthesis and spectroscopic properties of a new glaserite material, K3RE(VO4)2 (RE = Sc, Y, Dy, Ho, Er, Yb, Lu, or Tm) with potential lasing and optical properties. Inorg Chem. 2012;51(24):13271-80doi: 10.1021/ic301922e.
Kimani, M. M., Thompson, L., Snider, W., McMillen, C. D., & Kolis, J. W. (2012). Hydrothermal synthesis and spectroscopic properties of a new glaserite material, K3RE(VO4)2 (RE = Sc, Y, Dy, Ho, Er, Yb, Lu, or Tm) with potential lasing and optical properties. Inorganic chemistry, 51(24), 13271-80. https://doi.org/10.1021/ic301922e
Kimani, Martin M, et al. "Hydrothermal synthesis and spectroscopic properties of a new glaserite material, K3RE(VO4)2 (RE = Sc, Y, Dy, Ho, Er, Yb, Lu, or Tm) with potential lasing and optical properties." Inorganic chemistry vol. 51,24 (2012): 13271-80. doi: https://doi.org/10.1021/ic301922e
Kimani MM, Thompson L, Snider W, McMillen CD, Kolis JW. Hydrothermal synthesis and spectroscopic properties of a new glaserite material, K3RE(VO4)2 (RE = Sc, Y, Dy, Ho, Er, Yb, Lu, or Tm) with potential lasing and optical properties. Inorg Chem. 2012 Dec 17;51(24):13271-80. doi: 10.1021/ic301922e. Epub 2012 Dec 03. PMID: 23205611.
Copy Download .nbib Format: NLM
Interactions of fluorescent cholinergic antagonists with the membrane-bound acetylcholine receptor.

Neurochemistry international

Tan YP, Stender W, Harvey AL, Soria B, Barrantes FJ.
PMID: 20487792
Neurochem Int. 1980;2:257-67. doi: 10.1016/0197-0186(80)90033-9.

The synthesis of pyrenyl-choline derivatives is reported. The interactions of these compounds with the acetylcholine receptor has been studied in developing chick myotubes in culture and in the adult frog neuromuscular junction with electrophysiological techniques. In vivo, the compounds...

Cite
Tan YP, Stender W, Harvey AL, et al. Interactions of fluorescent cholinergic antagonists with the membrane-bound acetylcholine receptor. Neurochem Int. 1980;2:257-67doi: 10.1016/0197-0186(80)90033-9.
Tan, Y. P., Stender, W., Harvey, A. L., Soria, B., & Barrantes, F. J. (1980). Interactions of fluorescent cholinergic antagonists with the membrane-bound acetylcholine receptor. Neurochemistry international, 2257-67. https://doi.org/10.1016/0197-0186(80)90033-9
Tan, Y P, et al. "Interactions of fluorescent cholinergic antagonists with the membrane-bound acetylcholine receptor." Neurochemistry international vol. 2 (1980): 257-67. doi: https://doi.org/10.1016/0197-0186(80)90033-9
Tan YP, Stender W, Harvey AL, Soria B, Barrantes FJ. Interactions of fluorescent cholinergic antagonists with the membrane-bound acetylcholine receptor. Neurochem Int. 1980;2:257-67. doi: 10.1016/0197-0186(80)90033-9. PMID: 20487792.
Copy Download .nbib Format: NLM
A population K-PD model analysis of long-term testosterone inhibition in prostate cancer patients undergoing intermittent androgen deprivation therapy.

Journal of pharmacokinetics and pharmacodynamics

DeJongh J, Ahsman M, Snelder N.
PMID: 33538922
J Pharmacokinet Pharmacodyn. 2021 Aug;48(4):465-477. doi: 10.1007/s10928-020-09736-7. Epub 2021 Feb 04.

Intermittent androgen deprivation therapy with gonadotropin-releasing-hormone (GnRH) agonists can prevent or delay disease progression and development of castration resistant prostate cancer for subpopulations of prostate cancer patients. It may also reduce risk and severity of side effects associated with...

Cite
DeJongh J, Ahsman M, Snelder N. A population K-PD model analysis of long-term testosterone inhibition in prostate cancer patients undergoing intermittent androgen deprivation therapy. J Pharmacokinet Pharmacodyn. 2021;48(4):465-477doi: 10.1007/s10928-020-09736-7.
DeJongh, J., Ahsman, M., & Snelder, N. (2021). A population K-PD model analysis of long-term testosterone inhibition in prostate cancer patients undergoing intermittent androgen deprivation therapy. Journal of pharmacokinetics and pharmacodynamics, 48(4), 465-477. https://doi.org/10.1007/s10928-020-09736-7
DeJongh, Joost, et al. "A population K-PD model analysis of long-term testosterone inhibition in prostate cancer patients undergoing intermittent androgen deprivation therapy." Journal of pharmacokinetics and pharmacodynamics vol. 48,4 (2021): 465-477. doi: https://doi.org/10.1007/s10928-020-09736-7
DeJongh J, Ahsman M, Snelder N. A population K-PD model analysis of long-term testosterone inhibition in prostate cancer patients undergoing intermittent androgen deprivation therapy. J Pharmacokinet Pharmacodyn. 2021 Aug;48(4):465-477. doi: 10.1007/s10928-020-09736-7. Epub 2021 Feb 04. PMID: 33538922.
Copy Download .nbib Format: NLM
The expression, localisation and interactome of pigeon CRY2.

Scientific reports

Balay SD, Hochstoeger T, Vilceanu A, Malkemper EP, Snider W, Dürnberger G, Mechtler K, Schuechner S, Ogris E, Nordmann GC, Ushakova L, Nimpf S, Keays DA.
PMID: 34645873
Sci Rep. 2021 Oct 13;11(1):20293. doi: 10.1038/s41598-021-99207-x.

Cryptochromes (CRY) are highly conserved signalling molecules that regulate circadian rhythms and are candidate radical pair based magnetoreceptors. Birds have at least four cryptochromes (CRY1a, CRY1b, CRY2, and CRY4), but few studies have interrogated their function. Here we investigate...

Cite
Balay SD, Hochstoeger T, Vilceanu A, et al. The expression, localisation and interactome of pigeon CRY2. Sci Rep. 2021;11(1):20293doi: 10.1038/s41598-021-99207-x.
Balay, S. D., Hochstoeger, T., Vilceanu, A., Malkemper, E. P., Snider, W., Dürnberger, G., Mechtler, K., Schuechner, S., Ogris, E., Nordmann, G. C., Ushakova, L., Nimpf, S., & Keays, D. A. (2021). The expression, localisation and interactome of pigeon CRY2. Scientific reports, 11(1), 20293. https://doi.org/10.1038/s41598-021-99207-x
Balay, Spencer D, et al. "The expression, localisation and interactome of pigeon CRY2." Scientific reports vol. 11,1 (2021): 20293. doi: https://doi.org/10.1038/s41598-021-99207-x
Balay SD, Hochstoeger T, Vilceanu A, Malkemper EP, Snider W, Dürnberger G, Mechtler K, Schuechner S, Ogris E, Nordmann GC, Ushakova L, Nimpf S, Keays DA. The expression, localisation and interactome of pigeon CRY2. Sci Rep. 2021 Oct 13;11(1):20293. doi: 10.1038/s41598-021-99207-x. PMID: 34645873; PMCID: PMC8514597.
Copy Download .nbib Format: NLM
Successful delivery after vaginal occlusion in addition to cerclage in a trachelectomy patient with recurrent second trimester pregnancy loss: a case report.

Clinical case reports

Sneider K, Poulsen MØ, Ottosen C, Langhoff-Roos J.
PMID: 25356275
Clin Case Rep. 2014 Aug;2(4):153-5. doi: 10.1002/ccr3.84. Epub 2014 Jun 03.

KEY CLINICAL MESSAGE: Pregnancy outcome after trachelectomy has high risk of complications such as second trimester pregnancy loss and preterm birth. We report beneficial effect of a simple procedure of vaginal occlusion in addition to cerclage in a patient...

Cite
Sneider K, Poulsen MØ, Ottosen C, et al. Successful delivery after vaginal occlusion in addition to cerclage in a trachelectomy patient with recurrent second trimester pregnancy loss: a case report. Clin Case Rep. 2014;2(4):153-5doi: 10.1002/ccr3.84.
Sneider, K., Poulsen, M. �. �., Ottosen, C., & Langhoff-Roos, J. (2014). Successful delivery after vaginal occlusion in addition to cerclage in a trachelectomy patient with recurrent second trimester pregnancy loss: a case report. Clinical case reports, 2(4), 153-5. https://doi.org/10.1002/ccr3.84
Sneider, Kirstine, et al. "Successful delivery after vaginal occlusion in addition to cerclage in a trachelectomy patient with recurrent second trimester pregnancy loss: a case report." Clinical case reports vol. 2,4 (2014): 153-5. doi: https://doi.org/10.1002/ccr3.84
Sneider K, Poulsen MØ, Ottosen C, Langhoff-Roos J. Successful delivery after vaginal occlusion in addition to cerclage in a trachelectomy patient with recurrent second trimester pregnancy loss: a case report. Clin Case Rep. 2014 Aug;2(4):153-5. doi: 10.1002/ccr3.84. Epub 2014 Jun 03. PMID: 25356275; PMCID: PMC4184653.
Copy Download .nbib Format: NLM
Use of the p-values as a size-dependent function to address practical differences when analyzing large datasets.

Scientific reports

Gómez-de-Mariscal E, Guerrero V, Sneider A, Jayatilaka H, Phillip JM, Wirtz D, Muñoz-Barrutia A.
PMID: 34686696
Sci Rep. 2021 Oct 22;11(1):20942. doi: 10.1038/s41598-021-00199-5.

Biomedical research has come to rely on p-values as a deterministic measure for data-driven decision-making. In the largely extended null hypothesis significance testing for identifying statistically significant differences among groups of observations, a single p-value is computed from sample...

Cite
Gómez-de-Mariscal E, Guerrero V, Sneider A, et al. Use of the p-values as a size-dependent function to address practical differences when analyzing large datasets. Sci Rep. 2021;11(1):20942doi: 10.1038/s41598-021-00199-5.
Gómez-de-Mariscal, E., Guerrero, V., Sneider, A., Jayatilaka, H., Phillip, J. M., Wirtz, D., & Muñoz-Barrutia, A. (2021). Use of the p-values as a size-dependent function to address practical differences when analyzing large datasets. Scientific reports, 11(1), 20942. https://doi.org/10.1038/s41598-021-00199-5
Gómez-de-Mariscal, Estibaliz, et al. "Use of the p-values as a size-dependent function to address practical differences when analyzing large datasets." Scientific reports vol. 11,1 (2021): 20942. doi: https://doi.org/10.1038/s41598-021-00199-5
Gómez-de-Mariscal E, Guerrero V, Sneider A, Jayatilaka H, Phillip JM, Wirtz D, Muñoz-Barrutia A. Use of the p-values as a size-dependent function to address practical differences when analyzing large datasets. Sci Rep. 2021 Oct 22;11(1):20942. doi: 10.1038/s41598-021-00199-5. PMID: 34686696; PMCID: PMC8536742.
Copy Download .nbib Format: NLM
The expression, localisation and interactome of pigeon CRY2.

Scientific reports

Balay SD, Hochstoeger T, Vilceanu A, Malkemper EP, Snider W, Dürnberger G, Mechtler K, Schuechner S, Ogris E, Nordmann GC, Ushakova L, Nimpf S, Keays DA.
PMID: 34645873
Sci Rep. 2021 Oct 13;11(1):20293. doi: 10.1038/s41598-021-99207-x.

Cryptochromes (CRY) are highly conserved signalling molecules that regulate circadian rhythms and are candidate radical pair based magnetoreceptors. Birds have at least four cryptochromes (CRY1a, CRY1b, CRY2, and CRY4), but few studies have interrogated their function. Here we investigate...

Cite
Balay SD, Hochstoeger T, Vilceanu A, et al. The expression, localisation and interactome of pigeon CRY2. Sci Rep. 2021;11(1):20293doi: 10.1038/s41598-021-99207-x.
Balay, S. D., Hochstoeger, T., Vilceanu, A., Malkemper, E. P., Snider, W., Dürnberger, G., Mechtler, K., Schuechner, S., Ogris, E., Nordmann, G. C., Ushakova, L., Nimpf, S., & Keays, D. A. (2021). The expression, localisation and interactome of pigeon CRY2. Scientific reports, 11(1), 20293. https://doi.org/10.1038/s41598-021-99207-x
Balay, Spencer D, et al. "The expression, localisation and interactome of pigeon CRY2." Scientific reports vol. 11,1 (2021): 20293. doi: https://doi.org/10.1038/s41598-021-99207-x
Balay SD, Hochstoeger T, Vilceanu A, Malkemper EP, Snider W, Dürnberger G, Mechtler K, Schuechner S, Ogris E, Nordmann GC, Ushakova L, Nimpf S, Keays DA. The expression, localisation and interactome of pigeon CRY2. Sci Rep. 2021 Oct 13;11(1):20293. doi: 10.1038/s41598-021-99207-x. PMID: 34645873; PMCID: PMC8514597.
Copy Download .nbib Format: NLM
PK/PD modeling of FXI antisense oligonucleotides to bridge the dose-FXI activity relation from healthy volunteers to end-stage renal disease patients.

CPT: pharmacometrics & systems pharmacology

Willmann S, Marostica E, Snelder N, Solms A, Jensen M, Lobmeyer M, Lensing AWA, Bethune C, Morgan E, Yu RZ, Wang Y, Jung SW, Geary R, Bhanot S.
PMID: 34085768
CPT Pharmacometrics Syst Pharmacol. 2021 Aug;10(8):890-901. doi: 10.1002/psp4.12663. Epub 2021 Jun 23.

IONIS-FXI

Cite
Willmann S, Marostica E, Snelder N, et al. PK/PD modeling of FXI antisense oligonucleotides to bridge the dose-FXI activity relation from healthy volunteers to end-stage renal disease patients. CPT Pharmacometrics Syst Pharmacol. 2021;10(8):890-901doi: 10.1002/psp4.12663.
Willmann, S., Marostica, E., Snelder, N., Solms, A., Jensen, M., Lobmeyer, M., Lensing, A. W. A., Bethune, C., Morgan, E., Yu, R. Z., Wang, Y., Jung, S. W., Geary, R., & Bhanot, S. (2021). PK/PD modeling of FXI antisense oligonucleotides to bridge the dose-FXI activity relation from healthy volunteers to end-stage renal disease patients. CPT: pharmacometrics & systems pharmacology, 10(8), 890-901. https://doi.org/10.1002/psp4.12663
Willmann, Stefan, et al. "PK/PD modeling of FXI antisense oligonucleotides to bridge the dose-FXI activity relation from healthy volunteers to end-stage renal disease patients." CPT: pharmacometrics & systems pharmacology vol. 10,8 (2021): 890-901. doi: https://doi.org/10.1002/psp4.12663
Willmann S, Marostica E, Snelder N, Solms A, Jensen M, Lobmeyer M, Lensing AWA, Bethune C, Morgan E, Yu RZ, Wang Y, Jung SW, Geary R, Bhanot S. PK/PD modeling of FXI antisense oligonucleotides to bridge the dose-FXI activity relation from healthy volunteers to end-stage renal disease patients. CPT Pharmacometrics Syst Pharmacol. 2021 Aug;10(8):890-901. doi: 10.1002/psp4.12663. Epub 2021 Jun 23. PMID: 34085768; PMCID: PMC8376138.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 50 entries